Literature DB >> 20080565

G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression.

Petronila Penela1, Verónica Rivas, Alicia Salcedo, Federico Mayor.   

Abstract

Cell cycle progression requires changes in the activity or levels of a variety of key signaling proteins. G protein-coupled receptor kinase 2 (GRK2) plays a central role in G protein-coupled receptor regulation. Recent research is uncovering its involvement in additional cellular functions, but the potential role of GRK2 in the cell cycle has not been addressed. We report that GRK2 protein levels are transiently down-regulated during the G2/M transition by a mechanism involving CDK2-mediated phosphorylation of GRK2 at Serine670, which triggers binding to the prolyl-isomerase Pin1 and subsequent degradation. Prevention of GRK2 phosphorylation at S670 impedes normal GRK2 down-regulation and markedly delays cell cycle progression. Interestingly, we find that endogenous GRK2 down-regulation is prevented on activation of the G2/M checkpoint by doxorubicin and that stabilized GRK2 levels in such conditions inversely correlate with the p53 response and the induction of apoptosis, suggesting that GRK2 participates in the regulatory network controlling cell cycle arrest and survival in such conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080565      PMCID: PMC2824312          DOI: 10.1073/pnas.0905778107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Mitotic kinases as regulators of cell division and its checkpoints.

Authors:  E A Nigg
Journal:  Nat Rev Mol Cell Biol       Date:  2001-01       Impact factor: 94.444

2.  Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis.

Authors:  T Hsu; D McRackan; T S Vincent; H Gert de Couet
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

3.  The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.

Authors:  Paola Zacchi; Monica Gostissa; Takafumi Uchida; Clio Salvagno; Fabio Avolio; Stefano Volinia; Ze'ev Ronai; Giovanni Blandino; Claudio Schneider; Giannino Del Sal
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

4.  Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.

Authors:  Yih-Cherng Liou; Akihide Ryo; Han-Kuei Huang; Pei-Jung Lu; Roderick Bronson; Fumihiro Fujimori; Takafumi Uchida; Tony Hunter; Kun Ping Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.

Authors:  S Goldstone; S Pavey; A Forrest; J Sinnamon; B Gabrielli
Journal:  Oncogene       Date:  2001-02-22       Impact factor: 9.867

6.  Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.

Authors:  Gerburg M Wulf; Yih-Cherng Liou; Akihide Ryo; Sam W Lee; Kun Ping Lu
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

7.  Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2.

Authors:  P Penela; A Elorza; S Sarnago; F Mayor
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

8.  Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors.

Authors:  K Peppel; A Jacobson; X Huang; J P Murray; M Oppermann; N J Freedman
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

Review 9.  G protein-coupled receptor kinase 2 (GRK2) in migration and inflammation.

Authors:  Petronila Penela; Cristina Murga; Catalina Ribas; Alicia Salcedo; María Jurado-Pueyo; Veronica Rivas; Ivette Aymerich; Federico Mayor
Journal:  Arch Physiol Biochem       Date:  2008-07       Impact factor: 4.076

Review 10.  The prolyl isomerase Pin1 in breast development and cancer.

Authors:  Gerburg Wulf; Akihide Ryo; Yih-Cherng Liou; Kun Ping Lu
Journal:  Breast Cancer Res       Date:  2003-01-28       Impact factor: 6.466

View more
  35 in total

Review 1.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

2.  Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.

Authors:  Zhengyu Wei; Reginald Hurtt; Michele Ciccarelli; Walter J Koch; Cataldo Doria
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 3.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 4.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

Review 5.  The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Authors:  Petronila Penela; Cristina Murga; Catalina Ribas; Vanesa Lafarga; Federico Mayor
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  G protein-coupled receptor kinase 4-induced cellular senescence and its senescence-associated gene expression profiling.

Authors:  Pingping Xiao; Xishi Huang; Lanzhen Huang; Jing Yang; Ang Li; Ke Shen; Philip B Wedegaertner; Xiaoshan Jiang
Journal:  Exp Cell Res       Date:  2017-09-11       Impact factor: 3.905

Review 7.  Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.

Authors:  Valeria Rudomanova; Burns C Blaxall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-25       Impact factor: 5.187

8.  Growth Arrest Specific 8 (Gas8) and G protein-coupled receptor kinase 2 (GRK2) cooperate in the control of Smoothened signaling.

Authors:  Tama Evron; Melanie Philipp; Jiuyi Lu; Alison R Meloni; Martin Burkhalter; Wei Chen; Marc G Caron
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

9.  si-RNA-Mediated Silencing of ADRBK1 Gene Attenuates Breast Cancer Cell Proliferation.

Authors:  Chen Zhang; Xianzhen Chen; Yongxin Li; Himaya S W A; Jie Wu; Xiujuan Shi; Xiaoqing Liu; Sekwon Kim
Journal:  Cancer Biother Radiopharm       Date:  2014-10       Impact factor: 3.099

10.  β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation.

Authors:  Mohsin Khan; Sadia Mohsin; Daniele Avitabile; Sailay Siddiqi; Jonathan Nguyen; Kathleen Wallach; Pearl Quijada; Michael McGregor; Natalie Gude; Roberto Alvarez; Douglas G Tilley; Walter J Koch; Mark A Sussman
Journal:  Circ Res       Date:  2012-12-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.